Comparative modelling of the human UDP-glucuronosyltransferases: Insights into structure and mechanism

References

• Baker D, Sali A. Protein structure prediction and structural genomics. Science 2001; 294: 93–96
   PubMed Web of Science ®Google Scholar
• Battaglia E, Senay C, Fournel-Gigleux S, Herber R, Siest G, Magdalou J. The chemical modification of human liver UDP-glucuronosyltransferase UGT1*6 reveals the involvement of a carboxyl group in catalysis. FEBS Letters 1994; 346: 146–150
   PubMed Web of Science ®Google Scholar
• Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The protein data bank. Nucleic Acids Research 2000; 28: 235–242
   PubMed Web of Science ®Google Scholar
• Bond CS. TopDraw: A sketchpad for protein structure topology cartoons. Bioinformatics 2003; 19: 311–312
   PubMed Web of Science ®Google Scholar
• Bowalgaha K, Elliot DJ, Mackenzie PI, Knights KM, Swedmark S, Miners JO. S-naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): Role of UGT2B7 in the elimination of naproxen. British Journal of Clinical Pharmacology 2005; 60: 423–433
   PubMed Web of Science ®Google Scholar
• Coffman BL, Rios GR, King CD, Tephly TR. Human UGT2B7 catalyzes morphine glucuronidation. Drug Metabolism and Disposition 1997; 25: 1–4
   PubMed Web of Science ®Google Scholar
• Cohen AF, Land GS, Breimer DD, Yuen WC, Winton C, Peck AW. Lamotrigine, a new anticonvulsant: Pharmacokinetics in normal humans. Clinical Pharmacology and Therapy 1987; 42: 535–541
   PubMed Web of Science ®Google Scholar
• Coutinho PM, Deleury E, Davies GJ, Henrissat B. An evolving hierarchical family classification for glycosyltransferases. Journal of Molecular Biology 2003; 328: 307–317
   PubMed Web of Science ®Google Scholar
• Ethell BT, Ekins S, Wang J, Burchell B. Quantitative structure–activity relationships for the glucuronidation of simple phenols by expressed human UGT1A6 and UGT1A9. Drug Metabolism and Disposition 2002; 30: 734–738
   PubMed Web of Science ®Google Scholar
• Fisher MB, Campanale K, Ackermann BL, VandenBranden M, Wrighton SA. In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin. Drug Metabolism and Disposition 2000; 28: 560–566
   PubMed Web of Science ®Google Scholar
• Fisher MB, Paine MF, Strelevitz TJ, Wrighton SA. The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism. Drug Metabolism Reviews 2001; 33: 273–297
   PubMed Web of Science ®Google Scholar
• Franco OL, Rigden DJ. Fold recognition analysis of glycosyltransferase families: Further members of structural superfamilies. Glycobiology 2003; 13: 707–712
   PubMed Web of Science ®Google Scholar
• Green MD, Bishop WP, Tephly TR. Expressed human UGT1.4 protein catalyzes the formation of quaternary ammonium-linked glucuronides. Drug Metabolism and Disposition 1995; 23: 299–302
   PubMed Web of Science ®Google Scholar
• Hall TA. BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symposium Series 1999; 41: 95–98
   Google Scholar
• Hulo N, Bairoch A, Bulliard V, Cerutti L, De Castro E, Langendijk-Genevaux PS, Pagni M, Sigrist CJ. The PROSITE database. Nucleic Acids Research 2006; 34: D227–D230
   PubMed Web of Science ®Google Scholar
• Johnson EF, Stout CD. Structural diversity of human xenobiotic-metabolizing cytochrome P450 monooxygenases. Biochemistry and Biophysics Research Communications 2005; 338: 331–336
   PubMed Web of Science ®Google Scholar
• Kapitonov D, Yu RK. Conserved domains of glycosyltransferases. Glycobiology 1999; 9: 961–978
   PubMed Web of Science ®Google Scholar
• Kelley LA, MacCallum RM, Sternberg MJ. Enhanced genome annotation using structural profiles in the program 3D-PSSM. Journal of Molecular Biology 2000; 299: 499–520
   PubMed Web of Science ®Google Scholar
• Kurkela M, Morsky S, Hirvonen J, Kostiainen R, Finel M. An active and water-soluble truncation mutant of the human UDP-glucuronosyltransferase 1A9. Molecular Pharmacology 2004; 65: 826–831
   PubMed Web of Science ®Google Scholar
• Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: A program to check the stereochemical quality of protein structures. Journal of Applied Crystallography 1993; 26: 283–291
   Web of Science ®Google Scholar
• Luukkanen L, Taskinen J, Kurkela M, Kostiainen R, Hirvonen J, Finel M. Kinetic characterization of the 1A subfamily of recombinant human UDP-glucuronosyltransferases. Drug Metabolism and Disposition 2005; 33: 1017–1026
   PubMed Web of Science ®Google Scholar
• Mackenzie PI, Walter BK, Burchell B, Guillemette C, Ikushiro S, Iyanagi T, Miners JO, Owens IS, Nebert DW. Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenetics and Genomics 2005; 15: 677–685
   PubMed Web of Science ®Google Scholar
• Marchler-Bauer A, Anderson JB, Cherukuri PF, DeWeese-Scott C, Geer LY, Gwadz M, He S, Hurwitz DI, Jackson JD, Ke Z, et al. CDD: A conserved domain database for protein classification. Nucleic Acids Research 2005; 33: D192–D196
   PubMed Web of Science ®Google Scholar
• McGuffin LJ, Bryson K, Jones DT. The PSIPRED protein structure prediction server. Bioinformatics 2000; 16: 404–405
   PubMed Web of Science ®Google Scholar
• Meech R, Mackenzie PI. UDP-glucuronosyltransferase, the role of the amino terminus in dimerization. Journal of Biology and Chemistry 1997; 272: 26913–26917
   PubMed Web of Science ®Google Scholar
• Miners JO, Mackenzie PI. Drug glucuronidation in humans. Pharmacology and Therapy 1991; 51: 347–369
   PubMed Web of Science ®Google Scholar
• Ouzzine M, Antonio L, Burchell B, Netter P, Fournel-Gigleux S, Magdalou J. Importance of histidine residues for the function of the human liver UDP-glucuronosyltransferase UGT1A6: Evidence for the catalytic role of histidine 370. Molecular Pharmacology 2000; 58: 1609–1615
   PubMed Web of Science ®Google Scholar
• Qasba PK, Ramakrishnan B, Boeggeman E. Substrate-induced conformational changes in glycosyltransferases. Trends in Biochemistry Science 2005; 30: 53–62
   PubMed Web of Science ®Google Scholar
• Radominska-Pandya A, Czernik PJ, Little JM, Battaglia E, Mackenzie PI. Structural and functional studies of UDP-glucuronosyltransferases. Drug Metabolism Reviews 1999; 31: 817–899
   PubMed Web of Science ®Google Scholar
• Ross J, Li Y, Lim E, Bowles DJ. Higher plant glycosyltransferases. 2001, Genome Biology 2: Reviews, 2:3004.1–3004.6
   Google Scholar
• Rossman MG, Moras D, Olsen KW. Chemical and biological evaluation of a nucleotide-binding protein. Nature 1974; 250: 194–199
   PubMed Web of Science ®Google Scholar
• Schwede T, Kopp J, Guex N, Peitsch MC. SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Research 2003; 31: 3381–3385
   PubMed Web of Science ®Google Scholar
• Senay C, Ouzzine M, Battaglia E, Pless D, Cano V, Burchell B, Radominska A, Magdalou J, Fournel-Gigleux S. Arginine 52 and histidine 54 located in a conserved amino-terminal hydrophobic region (LX2-R52-G-H54-X3-V-L) are important amino acids for the functional and structural integrity of the human liver UDP-glucuronosyltransferase UGT1☆6. Molecular Pharmacology 1997; 51: 406–413
   PubMed Web of Science ®Google Scholar
• Shao H, He X, Achnine L, Blount JW, Dixon RA, Wang X. Crystal structures of a multifunctional triterpene/flavonoid glycosyltransferase from Medicago truncatula. Plant Cell 2005; 17: 3141–3154
   PubMed Web of Science ®Google Scholar
• Smith PA, Sorich MJ, Low LS, McKinnon RA, Miners JO. Towards integrated ADME prediction: Past, present and future directions for modelling metabolism by UDP-glucuronosyltransferases. Journal of Molecular Graphics and Modelling 2004; 22: 507–517
   PubMed Web of Science ®Google Scholar
• Stone AN, Mackenzie PI, Galetin A, Houston JB, Miners JO. Isoform selectivity and kinetics of morphine 3- and 6-glucuronidation by human UDP-glucuronosyltransferases: Evidence for atypical glucuronidation kinetics by UGT2B7. Drug Metabolism and Disposition 2003; 31: 1086–1089
   PubMed Web of Science ®Google Scholar
• Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Research 1994; 22: 4673–4680
   PubMed Web of Science ®Google Scholar
• Tsoutsikos P, Miners JO, Stapleton A, Thomas A, Sallustio BC, Knights KM. Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): Kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7. Biochemistry and Pharmacology 2004; 67: 191–199
   PubMed Web of Science ®Google Scholar
• Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: Metabolism, expression, and disease. Annual Reviews in Pharmacology and Toxicology 2000; 40: 581–616
   PubMed Web of Science ®Google Scholar
• Upton RA, Buskin JN, Williams RL, Holford NH, Riegelman S. Negligible excretion of unchanged ketoprofen, naproxen, and probenecid in urine. Journal of Pharmacology Science 1980; 69: 1254–1257
   PubMed Web of Science ®Google Scholar
• Zakim D, Hochman Y, Kenney WC. Evidence for an active site arginine in UDP-glucuronyltransferase. Journal of Biology and Chemistry 1983; 258: 6430–6434
   PubMed Web of Science ®Google Scholar